Apimeds Pharmaceuticals US, Inc. Share Price

Apimeds Pharmaceuticals US, Inc. Share Price

AMEX: APUS
$3.16
+$0.19 (6.40%) Last updated on 29 Oct, 2026 | 22:53 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Apimeds Pharmaceuticals US, Inc. Stock Performance

Open
$3.16
Prev. Close
$2.97
Circuit Range
N/A
Day Range
$3.16 - $3.16
Year Range
$0.62 - $9.71
Volume
200
Average Traded
$3.16

Apimeds Pharmaceuticals US, Inc. Share Price Today

As of 30 October 2026, Apimeds Pharmaceuticals US, Inc.'s share price is $3.16. The stock opened at $3.16, compared to its previous close of $2.97. During today's trading session, Apimeds Pharmaceuticals US, Inc.'s share price traded between $3.16 and $3.16, with an average price of $3.16. Over the past 52 weeks, the stock has recorded a high of $9.71 and a low of $0.62. In terms of performance, Apimeds Pharmaceuticals US, Inc.'s share price has risen by 84.80% over the last six months and is up 43.64% on a year-on-year basis.

Apimeds Pharmaceuticals US, Inc. Share Price Chart

Line chart of the Apimeds Pharmaceuticals US, Inc. price trend over the selected period. The price rose overall, ranging from 2.98 to 3.16, ending at 3.16.
$3.16$3.16
L
Show Current Price
H

Apimeds Pharmaceuticals US, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-38.55
Revenue (TTM)
$0.00
Return On Equity (TTM)
-54.65%
Profit Margin
N/A
Debt to Equity
0.08
Quarterly Earnings Growth YoY
-1033.15%

Apimeds Pharmaceuticals US, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.78-$1.16-$35.06-$20.17
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A34.83%-2922.41%42.47%

Apimeds Pharmaceuticals US, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$6.00
Net Profit MarginN/A
Income ChangeN/A

About Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being evaluated for the treatment of pain and inflammation associated with knee osteoarthritis. The Company operates in two segments: the biopharmaceutical segment, which is focused on the clinical development of Apitox through Lokahi, and the digital asset operations segment, which encompasses the holding, sale, and advancement of the MindWaveDAO blockchain and related digital assets through MindWave.

Apimeds Pharmaceuticals US, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$4.96
$3.16
-36.55%
Sep 2026
$2.57
$4.98
+1.22%
Aug 2026
$4.94
$4.92
-15.32%
Jul 2026
$0.89
$5.81
+583.53%
Jun 2026
$1.26
$0.85
-40.97%
May 2026
$5.77
$1.44
-15.79%
Apr 2026
$1.71
$1.71
-1.16%
Mar 2026
$1.43
$1.73
+37.85%
Feb 2026
$1.94
$1.25
-33.60%
Jan 2026
$1.73
$1.89
+2.72%
Dec 2025
$3.20
$1.84
-35.44%
Nov 2025
$2.18
$2.85
+29.55%

APUS Share Price FAQs